Since HIF-1 is well-known to regulate glycolysis [44], these results further underscored the apparent metabolic differences between primary and secondary prostate cancer and prompted us to investigate the contribution of the metastatic environment to the tumor metabolic phenotype in bone. This evidence concerns the gene HIF1A and prostate cancer.